Key Takeaways
- FDA Crackdown on GLP-1 Compounders: The FDA issued 30 warning letters to telehealth companies for misleading marketing of compounded GLP-1 products, signaling increased scrutiny.
- Lonza Divests CHI Business: Lonza is selling its Capsules & Health Ingredients division to Lone Star Funds for $3 billion, a major shift in the supplement supply chain.
- Vitamin D and Long COVID: A major clinical trial found that while high-dose vitamin D doesn't reduce COVID-19 severity, it may slightly reduce the chances of developing long COVID symptoms.
- Expo West Trends: Women's health, longevity (NAD+), and mental well-being (mushrooms and magnesium) were the standout trends at Natural Products Expo West 2026.
- Honey Products Recalled: Pure Vitamins and Natural Supplements recalled honey products after FDA analysis found undeclared sildenafil and tadalafil, highlighting ongoing quality control issues.
Top Stories
FDA Issues 30 Warning Letters to Telehealth Companies Marketing Compounded GLP-1s
The FDA has issued 30 warning letters to telehealth companies for marketing compounded GLP-1 products with claims that imply equivalence to FDA-approved drugs [1]. The letters focus on misleading marketing and branding that obscures the actual compounder of the products, building on earlier enforcement actions from September 2025. This action signals the FDA's increased scrutiny of the compounded drug market, particularly for popular products like GLP-1s, meaning supplement companies and telehealth platforms need to be cautious about their marketing claims and ensure transparency in their branding and supply chain.
Lonza Divests Capsules & Health Ingredients Business for $3 Billion
Lonza has agreed to sell its Capsules & Health Ingredients (CHI) division to private equity firm Lone Star Funds for an enterprise value of $3 billion, while retaining a 40% stake [2]. This divestment is part of Lonza's strategy to become a pure-play contract development and manufacturing organization (CDMO) for the pharmaceutical and biotech industries. This is a major shift in the supplement ingredient landscape, as Lonza's CHI business is a significant supplier of capsules and other ingredients to the nutraceutical industry, and the sale could lead to changes in strategy, investment, and pricing for a key component of the supplement supply chain.
Business and Investment
Icelandirect Acquires SOMA LABS
Icelandirect, a contract manufacturer of supplements, has acquired SOMA LABS, a New Jersey-based manufacturer specializing in solid dosage forms [3]. This acquisition will allow Icelandirect to expand its manufacturing capabilities beyond lipids and softgels to include powders, tablets, capsules, and chewables for both human and pet supplements. This acquisition signals a move towards vertical integration and offering a turnkey solution for supplement brands, allowing Icelandirect to control more of the manufacturing process and offer a wider range of product formats to its clients.
Ferrero's Bold Snacks Deal Signals Shift in Snacking Strategy
The Ferrero Group, known for its confectionery brands, has acquired Bold Snacks, a Brazilian protein snack company [4]. This move is part of Ferrero's strategy to diversify its portfolio and expand into the better-for-you snacking category. This acquisition highlights a significant trend of large, traditional food companies moving into the health and wellness space, as consumers increasingly seek out functional and protein-fortified snacks.
Science and Research
Scientists Tested Vitamin D for COVID and Found an Unexpected Long COVID Clue
A major clinical trial led by Mass General Brigham found that high-dose vitamin D3 did not make COVID-19 infections less severe or reduce hospital visits [5]. However, researchers spotted a possible signal that the supplement may reduce the chances of developing long COVID, with 21% of consistent vitamin D users reporting lingering symptoms compared to 25% in the placebo group. This large, rigorous study provides strong evidence that vitamin D does not prevent severe COVID-19, but the potential link to reducing long COVID symptoms warrants further investigation and could open up new avenues for managing this condition. For those looking to support their immune system year-round, our Vitamin D3 + K2 provides an optimal daily dose.
Processing-Induced Modulation of Beetroot Variants Targeting Enhanced Iron Retention
A new study investigated how different processing methods of beetroot affect iron retention and absorption [6]. The researchers found that pressure cooking beetroot with both juice and residue was the most effective method for enhancing iron bioavailability, while reducing anti-nutritional factors. This research offers a practical approach for the supplement industry to develop more effective iron supplements from natural sources like beetroot, potentially offering a food-based solution for iron deficiency.
New Product Launches and Formulation
Big Bold Health's Immunity Chews Win 2026 NEXTY Award
Big Bold Health's Immunity Chews, a supplement featuring Himalayan Tartary Buckwheat (HTB) sprout powder, won the 2026 NEXTY Award in the "Supplement for the Body" category at Natural Products Expo West [7]. The chews combine HTB with zinc, magnesium, and vitamins C and D, delivering convenient daily support for immune health and cellular energy. This award highlights the industry's recognition of innovative, food-based ingredients like Himalayan Tartary Buckwheat and the growing consumer interest in products that support immune health.
Harnessing Postbiotics: Nutraceutical Innovations for the Gut Microbiome
The growing trend of postbiotics for gut health is highlighting new products and research from companies like Cargill, Kerry, Morinaga Nutritional Foods, and ADM [8]. Postbiotics, which are inactivated microbes, offer formulation advantages over probiotics and are being explored for various health benefits, including immunity, digestion, mood, and cognitive support. This trend signifies a shift in the gut health market, with companies investing in the research and development of postbiotics as a more stable and versatile alternative to probiotics. If you are looking to support your own gut microbiome, our Multispore Probiotic Complex offers a robust blend of beneficial strains.
Regulations and Quality
Pure Vitamins and Natural Supplements Recalls Honey Products
Pure Vitamins and Natural Supplements, LLC is voluntarily recalling "Boner Bear Honey," "Red Bull Extreme," and "Blue Bull Extreme" honey products [9]. FDA analysis found the products to contain undeclared sildenafil and tadalafil, the active ingredients in Viagra and Cialis, which can interact dangerously with nitrates found in some prescription drugs. This recall highlights the ongoing issue of undeclared active pharmaceutical ingredients in dietary supplements and serves as a reminder for companies to ensure the purity and safety of their products.
Moringa Supply Chains Under Scrutiny
Recent contamination incidents involving moringa products have highlighted vulnerabilities in botanical ingredient supply chains [10]. Experts emphasize the need for multi-stage testing, supply chain transparency, and robust regulatory oversight to mitigate risks, noting that a two-tier supply chain has emerged with different levels of traceability and quality control. This story underscores the complexities and risks in sourcing botanical ingredients, serving as a reminder for supplement companies to prioritize supplier verification and testing.
Marketing and Consumer Trends
Ingredient Trendspotting: Top Insights from Natural Products Expo West
The recent Natural Products Expo West 2026 highlighted major trends in the supplement industry, with women's health, particularly menopause and cognitive function, taking center stage [11]. Longevity supplements featuring NAD+ and its precursors were also prominent, alongside adaptogens, nootropics, mushrooms, and magnesium for mental well-being. This provides a snapshot of where the industry is heading in terms of product development and consumer demand, highlighting key growth areas for brands to focus on. For those seeking mental well-being and relaxation, our Magnesium Glycinate is a highly bioavailable option.
AI in Life Sciences Market to Reach $73.05 Billion by 2040
A new report forecasts that the AI in life sciences market will grow from $5.69 billion to $73.05 billion by 2040, driven by the increasing volume of health data and the demand for personalized medicine [12]. This report highlights the immense financial investment and growth potential of AI within the life sciences sector, indicating a significant opportunity for the supplement industry to leverage AI for product development, personalization, and operational efficiency.
About the Author
Ben Law is the Founder of Love Life Supplements. He is passionate about health, fitness, and providing high-quality, clean supplements to help people live their best lives. Learn more about Ben's journey and the philosophy behind LLS at his founder page.
References
- Venable LLP. "FDA's Latest GLP 1 Crackdown: What Compounders and Telehealth Platforms Need to Know."
- Nutraceutical Business Review. "Lonza divests Capsules & Health Ingredients business to Lone Star Funds for $3bn."
- Yahoo Finance. "Icelandirect Acquires SOMA LABS."
- Confectionery News. "Ferrero's Bold Snacks deal signals shift in snacking strategy."
- ScienceDaily. "Scientists tested vitamin D for COVID and found an unexpected long COVID clue."
- Nature. "Processing-induced modulation of beetroot variants targeting enhanced iron retention."
- Yahoo Finance. "Big Bold Health's Immunity Chews Win 2026 NEXTY Award."
- Nutrition Insight. "Harnessing postbiotics: Nutraceutical innovations for the gut microbiome."
- FDA. "Pure Vitamins and Natural Supplements, LLC Issues Voluntary Nationwide Recall."
- Food Safety Magazine. "Moringa Supply Chains Under Scrutiny."
- SupplySide Supplement Journal. "Ingredient trendspotting: Top insights from Natural Products Expo West."
- Yahoo Finance. "AI in Life Sciences Market to Reach $73.05 Billion by 2040."